Tamoxifen Citrate Teva

Trials studying Tamoxifen Citrate Teva

• phase3A Phase III Trial Comparing HRS-8080 With Standard Endocrine Therapy in Patients With High-Risk Early Breast Cancerrecruitingn=4,800
• phase2Testing an Active Form of Tamoxifen (4-hydroxytamoxifen) Delivered Through Breast Skin to Control Ductal Carcinoma in Situ (DCIS) of the Breastcompletedn=100
• phase2The Effects of Short-term Preoperative Treatment With Hormonal Therapy on Gene Profiles in Breast Cancercompletedn=30
• phase2Limited Adjuvant Endocrine Therapy for Low Risk Breast Canceractive not recruitingn=290